avami

Avami refers to a brand of prescription medication used to treat moderate to severe atopic dermatitis, commonly known as eczema, in adults. The active ingredient in Avami is crisaborole, a non-steroidal topical phosphodiesterase 4 (PDE4) inhibitor. PDE4 is an enzyme that plays a role in inflammation. By inhibiting PDE4, crisaborole is believed to reduce inflammation associated with atopic dermatitis.

Avami is formulated as an ointment and is applied to the affected areas of the skin twice daily. It is intended for short-term and intermittent long-term treatment of atopic dermatitis. The medication works by targeting the inflammatory pathways within the skin. It is generally recommended for patients who have not achieved adequate control with topical corticosteroids or for whom the use of topical corticosteroids is not advisable.

Common side effects associated with Avami include application site pain, burning, or stinging. Other potential side effects may include redness, itching, and rash at the application site. It is important for patients to follow their healthcare provider's instructions regarding the use of Avami and to report any persistent or bothersome side effects. Avami is a prescription-only medication and should only be used under the supervision of a qualified medical professional.